Several factors involved in success of repeat corneal grafts

Article

There are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients.

A study featured in Ophthalmology has confirmed there are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients. These factors include duration of success of initial graft, age of patient, location of surgery and post-op rejection and corneal neovascularization.

A large cohort investigation led by Dr Keryn A. Williams, Department of Ophthalmology, Flinders Medical Centre, Bedford Park, Australia, included 229 regrafts from a national register of corneal grafts. The study involved 177 eyes of 173 patients and regrafts that had been performed more than once in 16 eyes. The main outcome measure was graft survival- analysed using Kaplan-Meier plots and Cox proportional hazards regression.

It was found that graft survival was significantly worse for second and third grafts compared to the first keratoconus graft. Kaplan-Meier survival plots were 88%, 69% and 46% at 1, 5 and 15 years postgrafting for seconds grafts, respectively. For the third grafts the Meier survival plots were 65%, 49% and 33% at 1, 5 and 15 years postgrafting, respectively.

The risk factors linked to graft failure of repeat grafts included the surgery location, failure of the previous graft within 10 years of surgery, rejection episodes and corneal neovascularization postoperatively.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.